In a previous paper (Gillam, Heaf, Hoffbrand, and Hilton, 1964) it was shown that, contrary to widespread opinion, the presence of co-existing chronic bronchitis does not interfere with the treatment of bronchial carcinoma by radiotherapy. Patients with severe chronic bronchitis can be given the same dose of irradiation as those with mild bronchitis or with previously normal lungs. Survival after radiotherapy for bronchial carcinoma is not shortened by co-existing chronic bronchitis. The incidence of exacerbations of bronchitis both during and after radiotherapy is no more than might be expected in such a group of patients without irradiated lungs.
Chronic bronchitis has also been suggested as an aetiological factor in the development of radiation pneumonitis and fibrosis (Warren, 1942; Widmann, 1942; Rubin, Andrews, Paton, and Flick, 1958) . The clinical study described in our other paper suggests that this is not the case. Serial pulmonary function tests have been used to investigate these problems further and the results are reported here.
SELECTION OF PATIENTS
Patients with bronchial carcinoma, treated by irradiation in the department of radiotherapy of University College Hospital, were classified on their past history, before lung function tests were done, into three main groups:
Group 1: No history of chronic chest symptoms. We have called these patients the nonbronchitic group.
Group 2: A history of chronic cough with mucoid sputum, often called by the patient a morning cough or smoker's cough, but without attacks of purulent bronchitis and without breathlessness. We have referred to these patients as the mild bronchitic group. 1 Present address: Whittington Hospital, Archway, London, N.19 Group 3: A history of chronic cough with sputum and recurrent chest infections or breathlessness or both. This group will be referred to as the severe bronchitic group. A subgroup 3a was derived from group 3 and consisted of those patients in group 3 with a forced expiratory volume in one second (F.E.V.j.0) of 1,250 ml. or less. Group 3a thus consisted largely of those patients with the severest bronchitis of all.
Group 1 was similar to groups 2 and 3 in respect of age, sex, previous lung resections, and radiotherapy received. Group 1, however, contained a higher proportion of patients with more extensive and more anaplastic tumours. Groups 2 and 3 were comparable in all respects (see Gillam et al. (1964) for full details).
METHODS AND PROCEDURE
The F.E.V.i.o and forced vital capacity (F.V.C.) were measured with a low resistance spirometer (Bernstein, D'Silva, and Mendel, 1952) . Duplicate maximal values were recorded. Diffusing capacity (DLCO) was measured by a steady state carbon monoxide method (MacNamara, Prime, and Sinclair, 1959) . Mixed venous PCo2 was estimated by the rebreathing method of Campbell and Howell (1960) .
A semi-quantitative estimate of ventilation-perfusion inequalities in the lung was obtained from a record of the partial pressure of carbon dioxide (Pco2) in the expired air (Comroe, Forster, Dubois, Briscoe, and Carlsen, 1962) . The unpublished method used is based on the technique of Comroe and Fowler (1951) for estimating inequalities in ventilation. The Pco2 was measured throughout a full expiration from the end-inspiratory position using an instantaneous infrared carbon dioxide analyser. A simultaneous record of the volume of air expired was made. In this way it was possible to measure the rise in PCo2 in the expired air during expiration of 500 ml. (750 ml. to 1,250 ml.). This rise in PCo2 is greater in the presence of more marked ventilation-perfusion inequalities, being normally less than 3 mm. Hg.
All the lung function tests were performed with the 303 patient seated and at rest. They were carried out within one week of the start of treatment and at least four weeks after any thoracic surgery. The tests were repeated during and at the end of treatment, one month after the end of treatment, and at subsequent follow-up visits. (Table II) . We think, on the basis of these figures, that the selection of patients for follow-up tests was not biased. The mean F.E.V.1 0 and F.V.C. were higher than the initial values for all groups, both at the end of treatment and one month later (Table III) . The improvement was similar in all groups, being, if anything, rather greater in the more bronchitic patients. Scattergrams were constructed for each group plotting absolute changes in F.E.V.5*0 and F.V.C. at the end of treatment and one month later against the pre-treatment values. These showed no correlation in any group. There is thus no evidence that the mean figures conceal any trend for patients with poor respiratory function and bronchitis to deteriorate with irradiation.
RESULTS
The F.E.V.50 is a measure of airways obstruction which is the most specific functional change in chronic bronchitis. There is therefore no evidence that patients with chronic bronchitis undergoing radiotherapy for carcinoma of the bronchus suffer increased airways obstruction. The expired CO2 test is sufficiently sensitive to show the expected differences in the degree of ventilation-perfusion inequalities between groups 1, 2, and 3 (Table V) . Thus, even in the complicating presence of bronchial carcinoma, the inequalities were greatest in the more severely bronchitic group 3 and least in the non-bronchitic group 1, the difference between the severe bronchitic and non-bronchitic groups being statistically significant.' The mean percentage change in the expired He gave a history of morning cough and sputum with occasional winter wheezing for years and was classified as group 2. Initial spirometry was F.E.V./F.V.C.= 2,250/3,250. A tumour dose of 4,400 r was given by telecobalt over 39 days. One week before the end of treatment he complained of breathlessness for the first time. This symptom increased over the next month, with night sweats, and at this time his chest radiograph showed marked unilateral radiation changes. Prednisone gave excellent symptomatic relief, but he died of carcinomatosis 28 weeks after the start of treatment. His lung function changes are shown in Figure 3 . There was a large increase in minute ventilation with a low Pco2, a sharp fall in DLcO from the onset of symptoms, and a less marked fall in F.V.C. These are the changes of the so-called 'alveolar-capillary block' syndrome.
RADIATION PNEUMONITIS
Illustrative case report A 59-year-old man was found to have an inoperable oat-cell bronchial carcinoma.
I Calculated using Student t tables and applying Bessel's correction when small numbers are involved.
DISCUSSION
There have been several investigations of the effect on lung function of radiotherapy for carcinoma of the bronchus (Catterall and Ogilvie, 1959; Sutton, Effect of chronic bronchitis on changes in pulmonary function after radiotherapy 1960; Deeley, 1960; Voutilainen, Mahonen, and Heinonen, 1962) . In none has the possible significance of the frequently co-existing chronic bronchitis been considered and evaluated.
Like us, other workers have found an improvement in spirometric values in the first few months after the start of treatment (Sutton, 1960; Deeley, 1960) . It seems reasonable to attribute these changes to shrinkage of the tumour. Such spirometric improvement might be expected to be greater in the non-bronchitic group 1, in whom the tumours were more extensive and a greater proportion were anaplastic and presumably more radiosensitive. However, the spirometric changes were greater in the most severely bronchitic patients (group 3a (Stone, Schwartz, and Green, 1956; Emirgil and Heinemann, 1961) . These workers have also found ventilation-perfusion inequalities in cases of radiation fibrosis uncomplicated by other lung disease. The lung volume changes found in our study show no tendency for patients with severe bronchitis to develop a restrictive abnormality. The DL,0 fell in all three groups, but the fall was least in the severely bronchitic patients of group 3. The Pco2 changes were small in all three groups, and there is no suggestion that patients with severe chronic bronchitis develop alveolar hyperventilation. This means that patients with chronic bronchitis undergoing radiotherapy for carcinoma of the bronchus show no special tendency to develop the lung function changes of radiation pneumonitis and fibrosis. This confirms the conclusions drawn on clinical grounds in our previous paper (Gillam et al., 1964) .
It is now appreciated that the DL,,, as a measure of gas transference from lungs to circulation, depends on several factors apart from diffusion across the 'alveolar-capillary membrane'. Among these factors are ventilation-perfusion ratios in the lungs. Indeed the functional changes in diffuse interstitial pulmonary fibrosis previously attributed to reduced alveolar-capillary diffusion can be fully explained by the presence of ventilation-perfusion inequalities (Holland, 1960; Finley, Swenson, and Comroe, 1962) . There was no evidence, however, that the changes in DL00 found in our patients were related to changes in ventilation-perfusion ratios. Alveolar exudate, thickening of alveolar septa, and vascular proliferative changes (which would reduce the pulmonary capillary bed) are frequent histological findings in irradiated lungs (Jennings and Arden, 1962) . The acute radiation reaction also reaches its peak one to two months after irradiation (Cooper, Guerrant, Harden, and Teates, 1961) . It seems possible, therefore, that the fall in DL.0 found in all groups one month after the end of treatment was due to subclinical radiation changes irrespective of the presence of chronic bronchitis.
SUMMARY
A serial lung function study has been made of patients having radiotherapy of the lungs for carcinoma of the bronchus. The changes found were compared in the three groups of patients, those without bronchitis, those with mild, and those with severe chronic bronchitis.
There is no evidence that patients with severe chronic bronchitis show any deterioration of the bronchitis; nor do they show any greater tendency to develop the functional changes of radiation pneumonitis and fibrosis.
Gas transference tends to fall one month after the end of treatment in all patients irrespective of the presence of chronic bronchitis. This could represent a subclinical radiation reaction in the lungs.
We think that radiotherapy (as given at University College Hospital) should not be withheld from patients with severe chronic bronchitis for fear of exacerbating the bronchitis or inducing radiation pneumonitis and fibrosis.
